Found: 23
Select item for more details and to access through your institution.
Low frequency of BK virus in prostatic adenocarcinomas.
- Published in:
- APMIS, 2007, v. 115, n. 6, p. 743, doi. 10.1111/j.1600-0463.2007.apm_601.x
- By:
- Publication type:
- Article
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.872756
- By:
- Publication type:
- Article
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 8, p. 914, doi. 10.1038/nm.3910
- By:
- Publication type:
- Article
Simultaneous Reconstitution of Multiple Cytomegalovirus-Specific CD8<sup>+</sup> Cell Populations with Divergent Functionality in Hematopoietic Stem-Cell Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2005, v. 191, n. 6, p. 977, doi. 10.1086/428136
- By:
- Publication type:
- Article
Relevance of Peptide Avidity to the T Cell Receptor for Cytomegalovirus-Specific Ex Vivo CD8 T Cell Cytotoxicity.
- Published in:
- Journal of Infectious Diseases, 2003, v. 188, n. 6, p. 908, doi. 10.1086/377582
- By:
- Publication type:
- Article
Human Immunodeficiency Virus-Infected Patients Receiving Highly Active Antiretroviral Therapy Maintain Activated CD8[sup+] T Cell Subsets as a Strong Adaptive Immune Response to Cytomegalovirus.
- Published in:
- Journal of Infectious Diseases, 2001, v. 184, n. 3, p. 256, doi. 10.1086/322028
- By:
- Publication type:
- Article
B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 851, doi. 10.1111/bjh.17397
- By:
- Publication type:
- Article
La Rosa C et al (J Infect Dis 2012; 205:1294–304).
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 8, p. 1294, doi. 10.1093/infdis/jis107
- By:
- Publication type:
- Article
Programmed Death-I Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 1, p. 25, doi. 10.1086/523652
- By:
- Publication type:
- Article
Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate-Early Antigen Polypeptides in Hematopoietic Stem-Cell Transplant and Solid Organ Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 10, p. 1410, doi. 10.1086/508495
- By:
- Publication type:
- Article
Neural Stem Cell-Mediated Delivery of Irinotecan-Activating Carboxylesterases to Glioma: Implications for Clinical Use.
- Published in:
- Stem Cells Translational Medicine, 2013, v. 2, n. 12, p. 983, doi. 10.5966/sctm.2012-0177
- By:
- Publication type:
- Article
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.669071
- By:
- Publication type:
- Article
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
- Published in:
- 2021
- By:
- Publication type:
- journal article
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 399, p. 1, doi. 10.1126/scitranslmed.aaa0984
- By:
- Publication type:
- Article
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 303, p. 1, doi. 10.1126/scitranslmed.aac5415
- By:
- Publication type:
- Article
Neurotoxicity after CTL019 in a pediatric and young adult cohort.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34<sup>+</sup> Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 36, p. 1, doi. 10.1126/scitranslmed.3000931
- By:
- Publication type:
- Article
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 10, p. 1, doi. 10.1371/journal.ppat.1006613
- By:
- Publication type:
- Article
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abn7336
- By:
- Publication type:
- Article